Kura Oncology Announces Data Presentation on Lead Product Candidate Tipifarnib at the Upcoming ASH Meeting
03 déc. 2015 07h00 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that new data from a Phase 3 trial of tipifarnib, the...
Kura Oncology to Present at the Oppenheimer 2015 Healthcare Conference
01 déc. 2015 07h00 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief...
Kura Oncology to Present at Upcoming Investor Conference
30 nov. 2015 18h40 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief...
Kura Oncology Announces First Patient Dosed in an Investigator-Sponsored Phase 2 Trial of Tipifarnib in Patients With HRAS Mutant Urothelial Cancer
30 nov. 2015 07h00 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), today announced that the first patient has been dosed in an investigator-sponsored Phase 2 trial of its lead drug...
Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference
11 nov. 2015 07h30 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief...
Kura Oncology Announces Pricing of Public Offering of Common Stock
04 nov. 2015 18h09 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...
Kura Oncology Announces Launch of Public Offering of Common Stock
28 oct. 2015 17h05 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (OTCQB:KURO), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid...
Kura Oncology Appoints Thomas Malley to Board of Directors
14 oct. 2015 07h30 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (OTCQB:KURO), a clinical stage biopharmaceutical company, today announced the appointment of Thomas Malley to its board of...
Kura Oncology Initiates Phase 2 Study of Tipifarnib in Peripheral T-cell Lymphoma
30 sept. 2015 07h30 HE
|
Kura Oncology, Inc.
LA JOLLA, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (OTCQB:KURO), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid...